Literature DB >> 16284607

Decreased risk of acute gastrointestinal toxicity when substituting methotrexate with mycophenolate mofetil in the prevention of graft-versus-host disease in stem cell transplantation following myeloablative conditioning regimens.

D Pohlreich, A Vitek, J Maalouf, P Cetkovsky.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16284607     DOI： 10.1038/sj.bmt.1705227

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN： 0268-3369            Impact factor:   5.483


× No keyword cloud information.
  2 in total

1.  Inferior Outcomes with Cyclosporine and Mycophenolate Mofetil after Myeloablative Allogeneic Hematopoietic Cell Transplantation.

Authors:  Betty K Hamilton; Ying Liu; Michael T Hemmer; Navneet Majhail; Olle Ringden; Dennis Kim; Luciano Costa; Robert Stuart; Amin Alousi; Joseph A Pidala; Daniel R Couriel; Mahmoud Aljurf; Joseph H Antin; Christopher Bredeson; Jean-Yves Cahn; Mitchell Cairo; Sung Won Choi; Christopher Dandoy; Robert Peter Gale; Usama Gergis; Peiman Hematti; Yoshihiro Inamoto; Rammurti T Kamble; Margaret MacMillan; David I Marks; Eneida Nemecek; Taiga Nishihori; Ayman Saad; Bipin N Savani; Jeff Schriber; Sachiko Seo; Gérard Socié; Takanori Teshima; Leo F Verdonck; Edmund K Waller; Mona Wirk; Stephen R Spellman; Mukta Arora; Saurabh Chhabra
Journal:  Biol Blood Marrow Transplant       Date:  2019-05-31       Impact factor: 5.742

2.  Comparison of cyclosporine and tacrolimus combined with mycophenolate mofetil in prophylaxis for graft-versus-host disease after reduced-intensity umbilical cord blood transplantation.

Authors:  Toshihiro Miyamoto; Shuichiro Takashima; Koji Kato; Ken Takase; Goichi Yoshimoto; Shuro Yoshida; Hideho Henzan; Koichi Osaki; Tomohiko Kamimura; Hiromi Iwasaki; Tetsuya Eto; Takanori Teshima; Koji Nagafuji; Koichi Akashi
Journal:  Int J Hematol       Date:  2016-09-29       Impact factor: 2.490
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.